NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • Getting involved with research
    • Researcher Guidance
    • Post an opportunity for patient and public involvement
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > COVID-19 > Oxford COVID-19 vaccinations begin

Oxford COVID-19 vaccinations begin

4 January 2021 · Listed under COVID-19, Vaccines for Emerging and Endemic Diseases

The NHS has launched the roll-out of the new Oxford AstraZeneca coronavirus vaccine, with patients at Oxford University Hospitals NHS Foundation Trust (OUH) the very first to get the life-saving jab.

Prof Andrew Pollard received the vaccination he helped to develop

Among the first to be vaccinated was Prof Andrew Pollard, the Oxford BRC investigator who has played a key role in developing the vaccine.

At 7.30am on Monday 4 January, dialysis patient Brian Pinker was vaccinated by Sam Foster, OUH Chief Nursing Officer at the Churchill Hospital in Oxford.

Brian, aged 82, a retired maintenance manager who has been having dialysis for kidney disease at the Churchill Hospital for a number of years, said: “I am so pleased to be getting the COVID vaccine today and really proud that it is one that was invented in Oxford.

“The nurses, doctors and staff today have all been brilliant and I can now really look forward to celebrating my 48th wedding anniversary with my wife Shirley later this year.”

Sam Foster added: “It was a real privilege to be able to deliver the first Oxford Vaccine at the Churchill Hospital here in Oxford, just a few hundred metres from where it was developed.

“We look forward to vaccinating many more patients and health and care staff with the Oxford Vaccine in the coming weeks, which will make a huge difference to people living in the communities we serve and the staff who care for them in our hospitals.”

Dr Bruno Holthof, OUH Chief Executive Officer, said: “We are very proud that the Churchill Hospital in Oxford was chosen to be the first location to provide the Oxford Vaccine.

“I would like to thank all our staff who have played their part in ensuring that we can deliver the vaccine for our patients and staff, and I would also like to pay tribute to the team here in Oxford who developed this vaccine in record time.”

Brian Pinker, an 82-year-old dialysis patient, was the first to receive the Oxford AstaZeneca vaccine

Alongside Brian Pinker, music teacher and father-of-three Trevor Cowlett, aged 88, and Professor Andrew Pollard, a paediatrican working at OUH who also pioneered the Oxford jab, were among the first to be vaccinated today.

Professor Pollard, Director of the Oxford Vaccine Group and Chief Investigator of the Oxford Vaccine Trial, said: “It was an incredibly proud moment for me to have received the actual vaccine that the University of Oxford and the AstraZeneca teams have worked so hard to make available to the UK and the world.

“As a paediatrician specialising in infections, I know how important it is that healthcare workers along with other priority groups are protected as soon as possible – a crucial role in defeating this terrible disease.”

For more information about the Oxford Vaccine please visit The Oxford Vaccine website.

← IBD treatments do not increase susceptibility to COVID-19, study finds
Oxford study confirms medium-term impact of COVID-19 →

News

  • Lymph nodes reveal more about mechanisms of autoimmunity 14 June 2022
  • Conference aims to forge collaborations to tackle dementia 9 June 2022
  • Lung function device wins top chemistry Prize 8 June 2022
See full news archive

News Categories

Month Archives

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2022 NIHR Oxford Biomedical Research Centre